Production (Stage)
Devonian Health Group Inc.
GSD.V
TSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.18M | 6.21M | 4.48M | 6.68M | 4.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.18M | 6.21M | 4.48M | 6.68M | 4.00M |
| Cost of Revenue | 3.28M | 4.37M | 3.04M | 4.16M | 2.85M |
| Gross Profit | 1.90M | 1.84M | 1.45M | 2.52M | 1.15M |
| SG&A Expenses | 1.46M | 1.24M | 1.48M | 1.37M | 1.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 22.00K | 22.60K | 23.20K | 21.80K | 22.00K |
| Total Operating Expenses | 5.20M | 6.04M | 4.90M | 5.79M | 4.21M |
| Operating Income | -21.30K | 170.80K | -416.80K | 883.60K | -209.80K |
| Income Before Tax | -3.38M | 147.30K | -444.30K | 789.40K | -275.50K |
| Income Tax Expenses | -- | 307.50K | -- | -- | 200.00K |
| Earnings from Continuing Operations | -3.38M | -160.30K | -444.30K | 789.40K | -475.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.38M | -160.30K | -444.30K | 789.40K | -475.50K |
| EBIT | -21.30K | 170.80K | -416.80K | 883.60K | -209.80K |
| EBITDA | 41.40K | 233.80K | -351.50K | 1.12M | -131.20K |
| EPS Basic | -0.02 | 0.00 | 0.00 | 0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.02 | 0.00 | 0.00 | 0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 148.22M | 148.22M | 148.22M | 148.23M | 147.54M |
| Average Diluted Shares Outstanding | 160.11M | 148.22M | 148.22M | 148.23M | 161.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |